Related Experiment Video

Updated: Jul 6, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Antiplatelet therapy for vascular interventions

Anthony J Comerota1, Subhash Thakur

  • 1University of Michigan, Ann Arbor, Michigan, USA. marilyn.gravett@promedica.org

Perspectives in Vascular Surgery and Endovascular Therapy
|April 5, 2008
PubMed

Insights

Platelet inhibition is crucial for patients with vascular disease undergoing revascularization. This review covers antiplatelet strategies for procedures like carotid endarterectomy and peripheral angioplasty.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Vascular Surgery

Background:

  • Platelets play a key role in vascular disease and thrombosis.
  • Platelet inhibition is vital for managing patients with advanced atherosclerotic disease.
  • Understanding antiplatelet benefits is essential for revascularization procedures.

Purpose of the Study:

  • To review the mechanisms of platelet inhibition.
  • To suggest antiplatelet strategies for various vascular interventions.
  • To highlight areas where platelet inhibition is less studied.

Main Methods:

  • Literature review of platelet function and antiplatelet agents.
  • Analysis of existing studies on platelet inhibition in vascular beds.
  • Synthesis of evidence to propose clinical strategies.

Main Results:

  • Platelet inhibition offers both general and procedure-specific benefits in vascular disease.
  • Limited data exists for platelet inhibition in aortoiliac, renal, and mesenteric arteries.
  • Carotid and infrainguinal vasculature have more studied antiplatelet protocols.

Conclusions:

  • Antiplatelet therapy is a cornerstone in managing patients undergoing vascular interventions.
  • Tailored antiplatelet strategies are needed, especially for less-studied vascular beds.
  • Further research is warranted to optimize antiplatelet use in all peripheral arterial systems.

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...